(19)
(11) EP 1 962 851 A2

(12)

(88) Date of publication A3:
29.11.2007

(43) Date of publication:
03.09.2008 Bulletin 2008/36

(21) Application number: 06840303.9

(22) Date of filing: 18.12.2006
(51) International Patent Classification (IPC): 
A61K 31/4745(2006.01)
C07D 471/02(2006.01)
(86) International application number:
PCT/US2006/062224
(87) International publication number:
WO 2007/076320 (05.07.2007 Gazette 2007/27)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
HR

(30) Priority: 22.12.2005 US 753217 P

(71) Applicant: SmithKline Beecham Corporation
Philadelphia, PA 19101 (US)

(72) Inventors:
  • HAMAJIMA, Toshihiro
    Ibaraki 300-4247 (JP)
  • NAKAMURA, Hiroko
    Ibaraki 300-4247 (JP)
  • TANG, Jun
    Drive PO Box 13398, Res. Triangle Park, NC 27709 (US)

(74) Representative: Learoyd, Stephanie Anne et al
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) COMPOUNDS